Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05586 | 33198849 | Br J Nutr | FNDC5 polymorphism influences the association between sarcopenia and liver fibrosis in adults with biopsy-proven non-alcoholic fatty liver disease. | 2020 | Details |
| A05587 | 33198247 | Nutrients | Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A05588 | 33198092 | Diagnostics (Basel) | Diagnostic Accuracy of FibroScan and Factors Affecting Measurements. | 2020 | Details |
| A05589 | 33197971 | J Paediatr Child Health | Liver disease in the older child. | 2020 | Details |
| A05590 | 33197790 | Environ Int | Unravelling the metabolic alterations of liver damage induced by thirdhand smoke. | 2020 | Details |
| A05591 | 33197764 | Biomed Pharmacother | Sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed Wistar rats. | 2020 | Details |
| A05592 | 33197060 | Magn Reson Med | Evaluation of hepatic steatosis before liver transplantation in ex vivo by volumetric quantitative PDFF-MRI. | 2020 | Details |
| A05594 | 33195636 | World J Clin Cases | Relationship between non-alcoholic fatty liver disease and coronary heart disease. | 2020 | Details |
| A05595 | 33195520 | Front Vet Sci | Lipid Accumulation and Injury in Primary Calf Hepatocytes Challenged With Different Long-Chain Fatty Acids. | 2020 | Details |
| A05596 | 33195347 | Front Med (Lausanne) | Neddylation: A Versatile Pathway Takes on Chronic Liver Diseases. | 2020 | Details |
| A05597 | 33195340 | Front Med (Lausanne) | Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A05598 | 33195326 | Front Med (Lausanne) | Hypoxia and Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A05599 | 33194991 | Front Public Health | Proteomic Characterization of Proliferation Inhibition of Well-Differentiated Laryngeal Squamous Cell Carcinoma Cells Under Below-Background Radiation in a Deep Underground Environment. | 2020 | Details |
| A05600 | 33194172 | Ther Adv Endocrinol Metab | The relation between serum adipose differentiation-related protein and non-alcoholic fatty liver disease in type 2 diabetes mellitus. | 2020 | Details |
| A05601 | 33194020 | Am J Transl Res | Development and validation of a nomogram for predicting nonalcoholic fatty liver disease in the non-obese Chinese population. | 2020 | Details |
| A05602 | 33193730 | Front Genet | Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases. | 2020 | Details |
| A05603 | 33193105 | Front Endocrinol (Lausanne) | Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH. | 2020 | Details |
| A05604 | 33193088 | Front Endocrinol (Lausanne) | Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity. | 2020 | Details |
| A05605 | 33191435 | Adv Nutr | Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease? | 2020 | Details |
| A05606 | 33191205 | Exp Cell Res | CKIP-1 augments autophagy in steatotic hepatocytes by inhibiting Akt/mTOR signal pathway. | 2020 | Details |
| A05608 | 33190588 | Autophagy | TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation. | 2020 | Details |
| A05609 | 33190346 | Liver Int | Pathophysiological mechanisms of liver injury in COVID-19. | 2020 | Details |
| A05610 | 33190175 | Obes Surg | Development and Validation of a Predictive Model of Success in Bariatric Surgery. | 2020 | Details |
| A05611 | 33190008 | Complement Ther Clin Pract | The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: A randomized controlled trial. | 2020 | Details |
| A05612 | 33188625 | J Physiol Biochem | Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway. | 2020 | Details |
| A05613 | 33187321 | Pharmaceuticals (Basel) | Germinated Soybean Embryo Extract Ameliorates Fatty Liver Injury in High-Fat Diet-Fed Obese Mice. | 2020 | Details |
| A05614 | 33187278 | Nutrients | The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD-A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | 2020 | Details |
| A05615 | 33187255 | Cells | Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence. | 2020 | Details |
| A05616 | 33187162 | Cells | Tissue-Resident Memory T Cells in the Liver-Unique Characteristics of Local Specialists. | 2020 | Details |
| A05617 | 33186794 | Biomed Pharmacother | Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. | 2020 | Details |
| A05618 | 33186758 | Mol Metab | Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD. | 2020 | Details |
| A05619 | 33186403 | PLoS One | Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients. | 2020 | Details |
| A05620 | 33186174 | J Comput Assist Tomogr | Quantification of Hepatic Fat Fraction in Patients With Nonalcoholic Fatty Liver Disease: Comparison of Multimaterial Decomposition Algorithm and Fat (Water)-Based Material Decomposition Algorithm Using Single-Source Dual-Energy Computed Tomography. | 2021 | Details |
| A05621 | 33186123 | Aging (Albany NY) | The nuclear and cytoplasmic roles of miR-320 in non-alcoholic fatty liver disease. | 2020 | Details |
| A05622 | 33185977 | Obesity (Silver Spring) | Can Baseline Characteristics be Used to Predict Liver Disease Outcomes in Pediatric Nonalcoholic Fatty Liver Disease? | 2020 | Details |
| A05623 | 33185911 | Hepatology | Neutral Ceramidase Mediates Nonalcoholic Steatohepatitis by Regulating Monounsaturated Fatty Acids and Gut IgA+ B Cells. | 2021 | Details |
| A05624 | 33185364 | N Engl J Med | A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. | 2020 | Details |
| A05625 | 33185134 | Xenobiotica | Pharmacokinetic changes of clozapine and norclozapine in a rat model of non-alcoholic fatty liver disease induced by orotic acid. | 2020 | Details |
| A05626 | 33184849 | J Cell Physiol | Co-option of PPARα in the regulation of lipogenesis and fatty acid oxidation in CLA-induced hepatic steatosis. | 2020 | Details |
| A05627 | 33184021 | Nanomedicine | Formulation and intestinal absorption of naringenin loaded nanostructured lipid carrier and its inhibitory effects on nonalcoholic fatty liver disease. | 2020 | Details |
| A05628 | 33183606 | Carbohydr Polym | Friend or foe? The roles of inulin-type fructans. | 2020 | Details |
| A05629 | 33182720 | Int J Environ Res Public Health | Resistance Exercise Regulates Hepatic Lipolytic Factors as Effective as Aerobic Exercise in Obese Mice. | 2020 | Details |
| A05630 | 33182700 | Nutrients | Fructose-Induced Intestinal Microbiota Shift Following Two Types of Short-Term High-Fructose Dietary Phases. | 2020 | Details |
| A05631 | 33182043 | Int Immunopharmacol | Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice. | 2020 | Details |
| A05632 | 33182038 | Int Immunopharmacol | Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88-mediated NF-κB and MAPK pathways and activating the Nrf2 pathway in mice. | 2020 | Details |
| A05633 | 33181119 | Lancet Gastroenterol Hepatol | Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa. | 2020 | Details |
| A05634 | 33181118 | Lancet Gastroenterol Hepatol | The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease. | 2020 | Details |
| A05635 | 33180143 | Eur J Nutr | A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier. | 2020 | Details |
| A05637 | 33179890 | Am Fam Physician | Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management. | 2020 | Details |
| A05639 | 33179077 | Mol Med Rep | In vitro analysis of hepatic stellate cell activation influenced by transmembrane 6 superfamily 2 polymorphism. | 2020 | Details |
| A05640 | 33178812 | Ann Transl Med | Diabetes and carotid artery disease: a narrative review. | 2020 | Details |
| A05641 | 33178320 | Evid Based Complement Alternat Med | Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway. | 2020 | Details |
| A05642 | 33177790 | World J Gastroenterol | Role of gut microbiota via the gut-liver-brain axis in digestive diseases. | 2020 | Details |
| A05643 | 33177712 | Nature | A reference map of potential determinants for the human serum metabolome. | 2020 | Details |
| A05644 | 33177586 | Sci Rep | Determinant components of newly onset versus improved metabolic syndrome in a population of Iran. | 2020 | Details |
| A05645 | 33177546 | Sci Rep | PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat. | 2020 | Details |
| A05646 | 33176658 | Curr Diabetes Rev | Dipeptidyl Peptidase IV Inhibitors for Nonalcoholic Fatty Liver Disease - Systematic Review and Metanalysis. | 2021 | Details |
| A05648 | 33173850 | SN Compr Clin Med | NAFLD and COVID-19: a Pooled Analysis. | 2020 | Details |
| A05649 | 33173745 | Adv Sci (Weinh) | The Nuclear Orphan Receptor NR2F6 Promotes Hepatic Steatosis through Upregulation of Fatty Acid Transporter CD36. | 2020 | Details |
| A05650 | 33173107 | Sci Rep | Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression. | 2020 | Details |
| A05651 | 33172809 | Dig Liver Dis | Leptin induces NAFLD progression through infiltrated CD8+ T lymphocytes mediating pyroptotic-like cell death of hepatocytes and macrophages. | 2020 | Details |
| A05652 | 33172399 | BMC Nephrol | Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study. | 2020 | Details |
| A05653 | 33171865 | Diagnostics (Basel) | Complications of Non-Alcoholic Fatty Liver Disease in Extrahepatic Organs. | 2020 | Details |
| A05654 | 33171747 | Int J Mol Sci | The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage. | 2020 | Details |
| A05655 | 33171699 | Diagnostics (Basel) | Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study. | 2020 | Details |
| A05656 | 35198030 | Evid Based Complement Alternat Med | Discovery of Quality Markers in Hugan Qingzhi Formula by Integrating a Lipid-Lowering Bioassay with UHPLC-QQQ-MS/MS. | 2020 | Details |
| A05657 | 33171266 | Transl Res | Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets. | 2020 | Details |
| A05658 | 33170809 | JCI Insight | Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans. | 2020 | Details |
| A05659 | 33169718 | J Res Health Sci | Dietary Total Antioxidant Capacity and Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study. | 2020 | Details |
| A05660 | 33169705 | Turk J Gastroenterol | Myeloperoxidase and calprotectin; Any role as non-invasive markers for the prediction of ınflammation and fibrosis in non-alcoholic steatohepatitis? | 2020 | Details |
| A05661 | 33169409 | Hepatology | Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH. | 2021 | Details |
| A05662 | 33169375 | Br J Pharmacol | Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases. | 2020 | Details |
| A05663 | 33168782 | Aging (Albany NY) | Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis. | 2020 | Details |
| A05664 | 33167594 | Int J Mol Sci | Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis. | 2020 | Details |
| A05665 | 33167521 | Int J Mol Sci | Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression. | 2020 | Details |
| A05666 | 33167328 | Int J Mol Sci | 9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes. | 2020 | Details |
| A05667 | 33166436 | Arch Endocrinol Metab | Hypoadiponectinemia as a marker of increased cardiovascular risk in patients with non-alcoholic fatty liver disease: correlation with albumin/creatinine ratio. | 2020 | Details |
| A05668 | 33166032 | Phytother Res | Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real-time two-dimensional shear wave elastography: A randomized clinical trial. | 2020 | Details |
| A05669 | 33165444 | Int J Clin Exp Pathol | Higher non-HDL-cholesterol to HDL-cholesterol ratio is linked to increase in non-alcoholic fatty liver disease: secondary analysis based on a longitudinal study. | 2020 | Details |
| A05670 | 33165307 | Panminerva Med | Noninvasive biomarkers in predicting nonalcoholic steatohepatitis and assessing liver fibrosis: systematic review and meta-analysis. | 2020 | Details |
| A05672 | 33164440 | Zhongguo Zhong Yao Za Zhi | [Study on improvement provided by water extracts of Polygoni Multiflori Radix and Polygoni Multiflori Radix Praeparata on non-alcoholic steatohepatitis in mice induced by MCD]. | 2020 | Details |
| A05673 | 33164439 | Zhongguo Zhong Yao Za Zhi | [Effect of Panax japonicus saponin Ⅳa on alleviating nonalcoholic steatohepatitis by regulating miR-17-5p/MFN2 signaling pathway]. | 2020 | Details |
| A05674 | 33164398 | Zhongguo Zhong Yao Za Zhi | [Mechanism of Alisma orientale in treating nonalcoholic fatty liver disease]. | 2020 | Details |
| A05675 | 33164304 | Liver Int | Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A05676 | 33163950 | JHEP Rep | NAFLD and liver transplantation: Disease burden, current management and future challenges. | 2020 | Details |
| A05677 | 33163832 | Hepatol Commun | Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis. | 2020 | Details |
| A05678 | 33163831 | Hepatol Commun | Loss of Hepatic Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Links Nonalcoholic Steatohepatitis to Atherosclerosis. | 2020 | Details |
| A05679 | 33162743 | Ann Gastroenterol | Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2020 | Details |
| A05680 | 33162737 | Ann Gastroenterol | Nonalcoholic fatty liver disease and atrial fibrillation: possible pathophysiological links and therapeutic interventions. | 2020 | Details |
| A05681 | 33161161 | Clin Gastroenterol Hepatol | Bariatric Surgery Versus Standard Obesity Treatment and the Risk of Severe Liver Disease: Data From the Swedish Obese Subjects Study. | 2020 | Details |
| A05682 | 33161047 | J Hepatol | Hepatokines and adipokines in NASH-related hepatocellular carcinoma. | 2020 | Details |
| A05683 | 33160101 | Mol Metab | Genetic and epigenetic factors determining NAFLD risk. | 2020 | Details |
| A05685 | 33159388 | FEBS Open Bio | MiR-22 modulates the expression of lipogenesis-related genes and promotes hepatic steatosis in vitro. | 2020 | Details |
| A05686 | 33158299 | Nutrients | Investigating Whether the Mediterranean Dietary Pattern Is Integrated in Routine Dietetic Practice for Management of Chronic Conditions: A National Survey of Dietitians. | 2020 | Details |
| A05687 | 33157318 | Clin Gastroenterol Hepatol | Clinical Utility of Change in Nonalcoholic Fatty Liver Disease Activity Score and Change in Fibrosis in NAFLD. | 2020 | Details |
| A05689 | 33157223 | J Ethnopharmacol | Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)-treated HepG2 cells. | 2020 | Details |
| A05690 | 33156104 | Am J Gastroenterol | Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment. | 2020 | Details |
| A05691 | 33155659 | Int J Mol Med | Role of Asxl2 in non‑alcoholic steatohepatitis‑related hepatocellular carcinoma developed from diabetes. | 2020 | Details |
| A05692 | 33153965 | Surg Obes Relat Dis | Use of noninvasive scores for advanced liver fibrosis can guide the need for hepatic biopsy during bariatric procedures. | 2020 | Details |
| A05693 | 33153126 | Nutrients | Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation. | 2020 | Details |